CXCL5	B:C1955899
Plays	O
a	O
Promoting	O
Role	O
in	O
Osteosarcoma	O
Cell	O
Migration	I:C0027627
and	I:C0027627
Invasion	I:C0027627
in	O
Autocrine	O
-	O
and	O
Paracrine	O
-	O
Dependent	O
Manners	O
CXCL5	O
,	O
a	O
CXC	O
-	I:C0282553
type	I:C0282553
chemokine	I:C0282553
,	O
is	O
an	O
important	O
attractant	O
for	O
granulocytic	O
immune	I:C0018183
cells	I:C0018183
by	O
binding	O
to	I:C1149468
its	I:C1149468
receptor	I:C1149468
CXCR2	I:C1149468
.	O

CXCL5	O
Plays	O
a	O
Promoting	O
Role	O
in	O
Osteosarcoma	B:C0029463
Cell	O
Migration	I:C0027627
and	I:C0027627
Invasion	I:C0027627
in	O
Autocrine	O
-	O
and	O
Paracrine	O
-	O
Dependent	O
Manners	O
CXCL5	O
,	O
a	O
CXC	O
-	I:C0282553
type	I:C0282553
chemokine	I:C0282553
,	O
is	O
an	O
important	O
attractant	O
for	O
granulocytic	O
immune	I:C0018183
cells	I:C0018183
by	O
binding	O
to	I:C1149468
its	I:C1149468
receptor	I:C1149468
CXCR2	I:C1149468
.	O

CXCL5	O
Plays	O
a	O
Promoting	O
Role	O
in	O
Osteosarcoma	O
Cell	B:C0027627
Migration	I:C0027627
and	I:C0027627
Invasion	I:C0027627
in	O
Autocrine	O
-	O
and	O
Paracrine	O
-	O
Dependent	O
Manners	O
CXCL5	O
,	O
a	O
CXC	O
-	I:C0282553
type	I:C0282553
chemokine	I:C0282553
,	O
is	O
an	O
important	O
attractant	O
for	O
granulocytic	O
immune	I:C0018183
cells	I:C0018183
by	O
binding	O
to	I:C1149468
its	I:C1149468
receptor	I:C1149468
CXCR2	I:C1149468
.	O

CXCL5	O
Plays	O
a	O
Promoting	O
Role	O
in	O
Osteosarcoma	O
Cell	O
Migration	I:C0027627
and	I:C0027627
Invasion	I:C0027627
in	O
Autocrine	B:C0596138
-	O
and	O
Paracrine	O
-	O
Dependent	O
Manners	O
CXCL5	O
,	O
a	O
CXC	O
-	I:C0282553
type	I:C0282553
chemokine	I:C0282553
,	O
is	O
an	O
important	O
attractant	O
for	O
granulocytic	O
immune	I:C0018183
cells	I:C0018183
by	O
binding	O
to	I:C1149468
its	I:C1149468
receptor	I:C1149468
CXCR2	I:C1149468
.	O

CXCL5	O
Plays	O
a	O
Promoting	O
Role	O
in	O
Osteosarcoma	O
Cell	O
Migration	I:C0027627
and	I:C0027627
Invasion	I:C0027627
in	O
Autocrine	O
-	O
and	O
Paracrine	O
-	O
Dependent	O
Manners	O
CXCL5	B:C1955899
,	O
a	O
CXC	O
-	I:C0282553
type	I:C0282553
chemokine	I:C0282553
,	O
is	O
an	O
important	O
attractant	O
for	O
granulocytic	O
immune	I:C0018183
cells	I:C0018183
by	O
binding	O
to	I:C1149468
its	I:C1149468
receptor	I:C1149468
CXCR2	I:C1149468
.	O

CXCL5	O
Plays	O
a	O
Promoting	O
Role	O
in	O
Osteosarcoma	O
Cell	O
Migration	I:C0027627
and	I:C0027627
Invasion	I:C0027627
in	O
Autocrine	O
-	O
and	O
Paracrine	O
-	O
Dependent	O
Manners	O
CXCL5	O
,	O
a	O
CXC	B:C0282553
-	I:C0282553
type	I:C0282553
chemokine	I:C0282553
,	O
is	O
an	O
important	O
attractant	O
for	O
granulocytic	O
immune	I:C0018183
cells	I:C0018183
by	O
binding	O
to	I:C1149468
its	I:C1149468
receptor	I:C1149468
CXCR2	I:C1149468
.	O

CXCL5	O
Plays	O
a	O
Promoting	O
Role	O
in	O
Osteosarcoma	O
Cell	O
Migration	I:C0027627
and	I:C0027627
Invasion	I:C0027627
in	O
Autocrine	O
-	O
and	O
Paracrine	O
-	O
Dependent	O
Manners	O
CXCL5	O
,	O
a	O
CXC	O
-	I:C0282553
type	I:C0282553
chemokine	I:C0282553
,	O
is	O
an	O
important	O
attractant	O
for	O
granulocytic	B:C0018183
immune	I:C0018183
cells	I:C0018183
by	O
binding	O
to	I:C1149468
its	I:C1149468
receptor	I:C1149468
CXCR2	I:C1149468
.	O

CXCL5	O
Plays	O
a	O
Promoting	O
Role	O
in	O
Osteosarcoma	O
Cell	O
Migration	I:C0027627
and	I:C0027627
Invasion	I:C0027627
in	O
Autocrine	O
-	O
and	O
Paracrine	O
-	O
Dependent	O
Manners	O
CXCL5	O
,	O
a	O
CXC	O
-	I:C0282553
type	I:C0282553
chemokine	I:C0282553
,	O
is	O
an	O
important	O
attractant	O
for	O
granulocytic	O
immune	I:C0018183
cells	I:C0018183
by	O
binding	B:C1149468
to	I:C1149468
its	I:C1149468
receptor	I:C1149468
CXCR2	I:C1149468
.	O

Recently	O
,	O
CXCL5	B:C1955899
/	O
CXCR2	O
has	O
been	O
found	O
to	O
play	O
an	O
oncogenic	O
role	O
in	O
many	O
human	O
cancers	O
.	O

Recently	O
,	O
CXCL5	O
/	O
CXCR2	B:C0527994
has	O
been	O
found	O
to	O
play	O
an	O
oncogenic	O
role	O
in	O
many	O
human	O
cancers	O
.	O

Recently	O
,	O
CXCL5	O
/	O
CXCR2	O
has	O
been	O
found	O
to	O
play	O
an	O
oncogenic	B:C0029005
role	O
in	O
many	O
human	O
cancers	O
.	O

Recently	O
,	O
CXCL5	O
/	O
CXCR2	O
has	O
been	O
found	O
to	O
play	O
an	O
oncogenic	O
role	O
in	O
many	O
human	B:C0086418
cancers	O
.	O

Recently	O
,	O
CXCL5	O
/	O
CXCR2	O
has	O
been	O
found	O
to	O
play	O
an	O
oncogenic	O
role	O
in	O
many	O
human	O
cancers	B:C0006826
.	O

However	O
,	O
the	O
exact	O
role	O
of	O
CXCL5	B:C1955899
in	O
osteosarcoma	O
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
has	O
not	O
been	O
revealed	O
.	O

However	O
,	O
the	O
exact	O
role	O
of	O
CXCL5	O
in	O
osteosarcoma	B:C0029463
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
has	O
not	O
been	O
revealed	O
.	O

However	O
,	O
the	O
exact	O
role	O
of	O
CXCL5	O
in	O
osteosarcoma	O
cell	B:C0027627
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
has	O
not	O
been	O
revealed	O
.	O

Here	O
we	O
found	O
that	O
the	O
protein	B:C1171362
expression	I:C1171362
of	O
CXCL5	O
was	O
significantly	O
increased	O
in	O
osteosarcoma	O
tissues	O
compared	O
with	O
that	O
in	O
matched	O
adjacent	I:C0040300
nontumor	I:C0040300
tissues	I:C0040300
.	O

Here	O
we	O
found	O
that	O
the	O
protein	O
expression	I:C1171362
of	O
CXCL5	B:C1955899
was	O
significantly	O
increased	O
in	O
osteosarcoma	O
tissues	O
compared	O
with	O
that	O
in	O
matched	O
adjacent	I:C0040300
nontumor	I:C0040300
tissues	I:C0040300
.	O

Here	O
we	O
found	O
that	O
the	O
protein	O
expression	I:C1171362
of	O
CXCL5	O
was	O
significantly	O
increased	O
in	O
osteosarcoma	B:C0029463
tissues	O
compared	O
with	O
that	O
in	O
matched	O
adjacent	I:C0040300
nontumor	I:C0040300
tissues	I:C0040300
.	O

Here	O
we	O
found	O
that	O
the	O
protein	O
expression	I:C1171362
of	O
CXCL5	O
was	O
significantly	O
increased	O
in	O
osteosarcoma	O
tissues	B:C0040300
compared	O
with	O
that	O
in	O
matched	O
adjacent	I:C0040300
nontumor	I:C0040300
tissues	I:C0040300
.	O

Here	O
we	O
found	O
that	O
the	O
protein	O
expression	I:C1171362
of	O
CXCL5	O
was	O
significantly	O
increased	O
in	O
osteosarcoma	O
tissues	O
compared	O
with	O
that	O
in	O
matched	B:C0040300
adjacent	I:C0040300
nontumor	I:C0040300
tissues	I:C0040300
.	O

Moreover	O
,	O
the	O
expression	B:C1171362
of	O
CXCL5	O
was	O
significantly	O
associated	O
with	O
advanced	O
clinical	O
stage	O
and	O
metastasis	O
.	O

Moreover	O
,	O
the	O
expression	O
of	O
CXCL5	B:C1435946
was	O
significantly	O
associated	O
with	O
advanced	O
clinical	O
stage	O
and	O
metastasis	O
.	O

Moreover	O
,	O
the	O
expression	O
of	O
CXCL5	O
was	O
significantly	O
associated	O
with	O
advanced	O
clinical	O
stage	O
and	O
metastasis	B:C4255448
.	O

Further	O
investigation	O
showed	O
that	O
the	O
CXCL5	B:C1955899
expression	O
levels	O
were	O
also	O
significantly	O
increased	O
in	O
osteosarcoma	O
cell	O
lines	I:C0085983
,	O
including	O
Saos	O
-	I:C0085983
2	I:C0085983
,	O
MG63	O
,	O
U2OS	O
,	O
and	O
SW1353	O
,	O
when	O
compared	O
with	O
those	O
in	O
normal	O
osteoblast	I:C0029418
hFoB1.19	O
cells	I:C0029418
.	O

Further	O
investigation	O
showed	O
that	O
the	O
CXCL5	O
expression	O
levels	O
were	O
also	O
significantly	O
increased	O
in	O
osteosarcoma	B:C0029463
cell	O
lines	I:C0085983
,	O
including	O
Saos	O
-	I:C0085983
2	I:C0085983
,	O
MG63	O
,	O
U2OS	O
,	O
and	O
SW1353	O
,	O
when	O
compared	O
with	O
those	O
in	O
normal	O
osteoblast	I:C0029418
hFoB1.19	O
cells	I:C0029418
.	O

Further	O
investigation	O
showed	O
that	O
the	O
CXCL5	O
expression	O
levels	O
were	O
also	O
significantly	O
increased	O
in	O
osteosarcoma	O
cell	B:C0085983
lines	I:C0085983
,	O
including	O
Saos	O
-	I:C0085983
2	I:C0085983
,	O
MG63	O
,	O
U2OS	O
,	O
and	O
SW1353	O
,	O
when	O
compared	O
with	O
those	O
in	O
normal	O
osteoblast	I:C0029418
hFoB1.19	O
cells	I:C0029418
.	O

Further	O
investigation	O
showed	O
that	O
the	O
CXCL5	O
expression	O
levels	O
were	O
also	O
significantly	O
increased	O
in	O
osteosarcoma	O
cell	O
lines	I:C0085983
,	O
including	O
Saos	B:C0085983
-	I:C0085983
2	I:C0085983
,	O
MG63	O
,	O
U2OS	O
,	O
and	O
SW1353	O
,	O
when	O
compared	O
with	O
those	O
in	O
normal	O
osteoblast	I:C0029418
hFoB1.19	O
cells	I:C0029418
.	O

Further	O
investigation	O
showed	O
that	O
the	O
CXCL5	O
expression	O
levels	O
were	O
also	O
significantly	O
increased	O
in	O
osteosarcoma	O
cell	O
lines	I:C0085983
,	O
including	O
Saos	O
-	I:C0085983
2	I:C0085983
,	O
MG63	B:C0085983
,	O
U2OS	O
,	O
and	O
SW1353	O
,	O
when	O
compared	O
with	O
those	O
in	O
normal	O
osteoblast	I:C0029418
hFoB1.19	O
cells	I:C0029418
.	O

Further	O
investigation	O
showed	O
that	O
the	O
CXCL5	O
expression	O
levels	O
were	O
also	O
significantly	O
increased	O
in	O
osteosarcoma	O
cell	O
lines	I:C0085983
,	O
including	O
Saos	O
-	I:C0085983
2	I:C0085983
,	O
MG63	O
,	O
U2OS	B:C0085983
,	O
and	O
SW1353	O
,	O
when	O
compared	O
with	O
those	O
in	O
normal	O
osteoblast	I:C0029418
hFoB1.19	O
cells	I:C0029418
.	O

Further	O
investigation	O
showed	O
that	O
the	O
CXCL5	O
expression	O
levels	O
were	O
also	O
significantly	O
increased	O
in	O
osteosarcoma	O
cell	O
lines	I:C0085983
,	O
including	O
Saos	O
-	I:C0085983
2	I:C0085983
,	O
MG63	O
,	O
U2OS	O
,	O
and	O
SW1353	B:C0085983
,	O
when	O
compared	O
with	O
those	O
in	O
normal	O
osteoblast	I:C0029418
hFoB1.19	O
cells	I:C0029418
.	O

Further	O
investigation	O
showed	O
that	O
the	O
CXCL5	O
expression	O
levels	O
were	O
also	O
significantly	O
increased	O
in	O
osteosarcoma	O
cell	O
lines	I:C0085983
,	O
including	O
Saos	O
-	I:C0085983
2	I:C0085983
,	O
MG63	O
,	O
U2OS	O
,	O
and	O
SW1353	O
,	O
when	O
compared	O
with	O
those	O
in	O
normal	B:C0029418
osteoblast	I:C0029418
hFoB1.19	O
cells	I:C0029418
.	O

Further	O
investigation	O
showed	O
that	O
the	O
CXCL5	O
expression	O
levels	O
were	O
also	O
significantly	O
increased	O
in	O
osteosarcoma	O
cell	O
lines	I:C0085983
,	O
including	O
Saos	O
-	I:C0085983
2	I:C0085983
,	O
MG63	O
,	O
U2OS	O
,	O
and	O
SW1353	O
,	O
when	O
compared	O
with	O
those	O
in	O
normal	O
osteoblast	I:C0029418
hFoB1.19	B:C0029418
cells	I:C0029418
.	O

U2OS	B:C0085983
cells	I:C0085983
were	O
further	O
transfected	O
with	O
CXCL5	O
-	O
specific	O
siRNA	I:C1099354
or	O
overexpression	O
plasmid	O
.	O

U2OS	O
cells	I:C0085983
were	O
further	O
transfected	B:C0314641
with	O
CXCL5	O
-	O
specific	O
siRNA	I:C1099354
or	O
overexpression	O
plasmid	O
.	O

U2OS	O
cells	I:C0085983
were	O
further	O
transfected	O
with	O
CXCL5	B:C1332819
-	O
specific	O
siRNA	I:C1099354
or	O
overexpression	O
plasmid	O
.	O

U2OS	O
cells	I:C0085983
were	O
further	O
transfected	O
with	O
CXCL5	O
-	O
specific	B:C1099354
siRNA	I:C1099354
or	O
overexpression	O
plasmid	O
.	O

U2OS	O
cells	I:C0085983
were	O
further	O
transfected	O
with	O
CXCL5	O
-	O
specific	O
siRNA	I:C1099354
or	O
overexpression	B:C1514559
plasmid	O
.	O

U2OS	O
cells	I:C0085983
were	O
further	O
transfected	O
with	O
CXCL5	O
-	O
specific	O
siRNA	I:C1099354
or	O
overexpression	O
plasmid	B:C0032136
.	O

Knockdown	B:C2350567
of	O
CXCL5	O
significantly	O
suppressed	O
U2OS	O
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
.	O

Knockdown	O
of	O
CXCL5	B:C1332819
significantly	O
suppressed	O
U2OS	O
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
.	O

Knockdown	O
of	O
CXCL5	O
significantly	O
suppressed	O
U2OS	B:C0085983
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
.	O

Knockdown	O
of	O
CXCL5	O
significantly	O
suppressed	O
U2OS	O
cell	B:C0027627
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
.	O

On	O
the	O
contrary	O
,	O
overexpression	B:C1514559
of	O
CXLC5	O
remarkably	O
promoted	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
.	O

On	O
the	O
contrary	O
,	O
overexpression	O
of	O
CXLC5	B:C1955899
remarkably	O
promoted	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
.	O

On	O
the	O
contrary	O
,	O
overexpression	O
of	O
CXLC5	O
remarkably	O
promoted	O
the	O
migration	B:C0027627
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
.	O

On	O
the	O
contrary	O
,	O
overexpression	O
of	O
CXLC5	O
remarkably	O
promoted	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	B:C0085983
cells	I:C0085983
.	O

Interestingly	O
,	O
both	O
exogenous	O
CXCL5	B:C1955899
treatment	O
and	O
the	O
conditioned	O
medium	O
of	O
CXCL5	O
-	O
overexpressing	O
hFoB1.19	O
cells	I:C0029418
could	O
also	O
enhance	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
CXCL5	O
in	O
U2OS	O
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
is	O
also	O
in	O
a	O
paracrine	O
-	O
dependent	O
manner	O
.	O

Interestingly	O
,	O
both	O
exogenous	O
CXCL5	O
treatment	O
and	O
the	O
conditioned	O
medium	O
of	O
CXCL5	B:C1955899
-	O
overexpressing	O
hFoB1.19	O
cells	I:C0029418
could	O
also	O
enhance	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
CXCL5	O
in	O
U2OS	O
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
is	O
also	O
in	O
a	O
paracrine	O
-	O
dependent	O
manner	O
.	O

Interestingly	O
,	O
both	O
exogenous	O
CXCL5	O
treatment	O
and	O
the	O
conditioned	O
medium	O
of	O
CXCL5	O
-	O
overexpressing	B:C1514559
hFoB1.19	O
cells	I:C0029418
could	O
also	O
enhance	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
CXCL5	O
in	O
U2OS	O
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
is	O
also	O
in	O
a	O
paracrine	O
-	O
dependent	O
manner	O
.	O

Interestingly	O
,	O
both	O
exogenous	O
CXCL5	O
treatment	O
and	O
the	O
conditioned	O
medium	O
of	O
CXCL5	O
-	O
overexpressing	O
hFoB1.19	B:C0029418
cells	I:C0029418
could	O
also	O
enhance	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
CXCL5	O
in	O
U2OS	O
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
is	O
also	O
in	O
a	O
paracrine	O
-	O
dependent	O
manner	O
.	O

Interestingly	O
,	O
both	O
exogenous	O
CXCL5	O
treatment	O
and	O
the	O
conditioned	O
medium	O
of	O
CXCL5	O
-	O
overexpressing	O
hFoB1.19	O
cells	I:C0029418
could	O
also	O
enhance	O
the	O
migration	B:C0027627
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
CXCL5	O
in	O
U2OS	O
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
is	O
also	O
in	O
a	O
paracrine	O
-	O
dependent	O
manner	O
.	O

Interestingly	O
,	O
both	O
exogenous	O
CXCL5	O
treatment	O
and	O
the	O
conditioned	O
medium	O
of	O
CXCL5	O
-	O
overexpressing	O
hFoB1.19	O
cells	I:C0029418
could	O
also	O
enhance	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	B:C0085983
cells	I:C0085983
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
CXCL5	O
in	O
U2OS	O
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
is	O
also	O
in	O
a	O
paracrine	O
-	O
dependent	O
manner	O
.	O

Interestingly	O
,	O
both	O
exogenous	O
CXCL5	O
treatment	O
and	O
the	O
conditioned	O
medium	O
of	O
CXCL5	O
-	O
overexpressing	O
hFoB1.19	O
cells	I:C0029418
could	O
also	O
enhance	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
CXCL5	B:C1955899
in	O
U2OS	O
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
is	O
also	O
in	O
a	O
paracrine	O
-	O
dependent	O
manner	O
.	O

Interestingly	O
,	O
both	O
exogenous	O
CXCL5	O
treatment	O
and	O
the	O
conditioned	O
medium	O
of	O
CXCL5	O
-	O
overexpressing	O
hFoB1.19	O
cells	I:C0029418
could	O
also	O
enhance	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
CXCL5	O
in	O
U2OS	B:C0085983
cell	O
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
is	O
also	O
in	O
a	O
paracrine	O
-	O
dependent	O
manner	O
.	O

Interestingly	O
,	O
both	O
exogenous	O
CXCL5	O
treatment	O
and	O
the	O
conditioned	O
medium	O
of	O
CXCL5	O
-	O
overexpressing	O
hFoB1.19	O
cells	I:C0029418
could	O
also	O
enhance	O
the	O
migration	O
and	I:C0027627
invasion	I:C0027627
of	O
U2OS	O
cells	I:C0085983
,	O
suggesting	O
that	O
the	O
promoting	O
role	O
of	O
CXCL5	O
in	O
U2OS	O
cell	B:C0027627
migration	I:C0027627
and	I:C0027627
invasion	I:C0027627
is	O
also	O
in	O
a	O
paracrine	O
-	O
dependent	O
manner	O
.	O

According	O
to	O
these	O
data	O
,	O
our	O
study	O
demonstrates	O
that	O
CXCL5	B:C1955899
is	O
upregulated	O
in	O
osteosarcoma	O
and	O
may	O
play	O
an	O
oncogenic	O
role	O
in	O
osteosarcoma	O
metastasis	O
.	O

According	O
to	O
these	O
data	O
,	O
our	O
study	O
demonstrates	O
that	O
CXCL5	O
is	O
upregulated	O
in	O
osteosarcoma	B:C0029463
and	O
may	O
play	O
an	O
oncogenic	O
role	O
in	O
osteosarcoma	O
metastasis	O
.	O

According	O
to	O
these	O
data	O
,	O
our	O
study	O
demonstrates	O
that	O
CXCL5	O
is	O
upregulated	O
in	O
osteosarcoma	O
and	O
may	O
play	O
an	O
oncogenic	B:C0029005
role	O
in	O
osteosarcoma	O
metastasis	O
.	O

According	O
to	O
these	O
data	O
,	O
our	O
study	O
demonstrates	O
that	O
CXCL5	O
is	O
upregulated	O
in	O
osteosarcoma	O
and	O
may	O
play	O
an	O
oncogenic	O
role	O
in	O
osteosarcoma	B:C0029463
metastasis	O
.	O

According	O
to	O
these	O
data	O
,	O
our	O
study	O
demonstrates	O
that	O
CXCL5	O
is	O
upregulated	O
in	O
osteosarcoma	O
and	O
may	O
play	O
an	O
oncogenic	O
role	O
in	O
osteosarcoma	O
metastasis	B:C4255448
.	O

Therefore	O
,	O
CXCL5	B:C1955899
may	O
become	O
a	O
potential	O
therapeutic	O
target	O
for	O
osteosarcoma	O
treatment	O
.	O

Therefore	O
,	O
CXCL5	O
may	O
become	O
a	O
potential	O
therapeutic	O
target	O
for	O
osteosarcoma	B:C0029463
treatment	O
.	O

